Lantheus Holdings, Inc. (LNTH)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Lantheus Holdings, Inc. (LNTH) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $6.59B, a trailing price-to-earnings ratio of 17.0 and a free-cash-flow yield of 5.0%. Over the most recent reported fiscal year, revenue grew 0.5% and free cash flow per share fell 21.5%.

Market cap	$6.59B
Trailing P/E	17.0
FCF yield	5.0%
Revenue growth (YoY)	+0.5%
EPS growth (YoY)	-10.9%
FCF/share growth (YoY)	-21.5%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live LNTH data on Nama Insights →

Recent Congressional trades

Lantheus Holdings, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 6, 2025
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 6, 2025